Economics and outcomes of sotalol in-patient dosing approaches in patients with atrial fibrillation.

ABSTRACT:

Introduction

There exists variability in the administration of in-patient sotalol therapy for symptomatic atrial fibrillation (AF). The impact of this variability on patient in-hospital and 30-day posthospitalization costs and outcomes is not known. Also, the cost impact of intravenous sotalol, which can accelerate drug loading to therapeutic levels, is unknown.

Methods

One hundred and thirty-three AF patients admitted for oral sotalol initiation at an Intermountain Healthcare Hospital from January 2017 to December 2018 were included. Patient and dosing characteristics were described descriptively and the impact of dosing schedule was correlated with daily hospital costs/clinical outcomes during the index hospitalization and for 30 days. The Centers for Medicare and Medicaid

SUBMITTER: Varela DL 

PROVIDER: S-EPMC9305518 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature